Chemoinformaics analysis of 7-hydroxy-5-methoxyflavanone
| Molecular Weight | 270.284 | nRot | 2 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 18 |
| Exact Molecular Weight | 270.089 | nRing | 3 |
| Solubility: LogS | -3.698 | nHRing | 1 |
| Solubility: LogP | 2.499 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 39.2631 |
| nHD | 1 | BPOL | 18.3849 |
| QED | 0.911 |
| Synth | 2.654 |
| Natural Product Likeliness | 1.595 |
| NR-PPAR-gamma | 0.829 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0 |
| HIA | 0.01 |
| CACO-2 | -4.644 |
| MDCK | 0.000017 |
| BBB | 0.428 |
| PPB | 0.895814 |
| VDSS | 0.571 |
| FU | 0.0587688 |
| CYP1A2-inh | 0.912 |
| CYP1A2-sub | 0.728 |
| CYP2c19-inh | 0.939 |
| CYP2c19-sub | 0.53 |
| CYP2c9-inh | 0.849 |
| CYP2c9-sub | 0.922 |
| CYP2d6-inh | 0.87 |
| CYP2d6-sub | 0.861 |
| CYP3a4-inh | 0.686 |
| CYP3a4-sub | 0.253 |
| CL | 12.171 |
| T12 | 0.456 |
| hERG | 0.043 |
| Ames | 0.279 |
| ROA | 0.477 |
| SkinSen | 0.37 |
| Carcinogencity | 0.54 |
| EI | 0.891 |
| Respiratory | 0.841 |
| NR-Aromatase | 0.058 |
| Antiviral | Yes |
| Prediction | 0.704543 |